Tomosynthesis in Screening Mammography
- Conditions
- Breast Density >25%
- Interventions
- Procedure: TomosynthesisProcedure: 2D Mammogram
- Registration Number
- NCT01086241
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
Tomosynthesis is a new digital mammographic tool which can be performed at the same time as routine screening mammography. It creates CT-like slices through the breast, minimizing the tissue overlap. Tomosynthesis has the potential to improve screening mammography outcomes by increasing cancer detection rates, decreasing false negative rates and false positive rates. This trial will help determine if tomosynthesis is useful in a screening setting.
- Detailed Description
We will evaluate the effect of tomosynthesis mammography outcomes in a screening setting. We will collect data on interpretation time, recall rates, cancer detection rates, and interval cancer rates in dense breasts(≥ 50% glandular density). If the interpretation time is less than 4X a routine read, and the recall rates have dropped \< 30% of initial values, we will then conduct a study with larger numbers to better evaluate cancer detection rates and interval cancer rates.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 500
- Females 40-69 years of age attending Screen Test Kingsway referred for a screening mammogram as defined by Canadian Cancer Society guidelines.
- Prior mammogram report indicating ≥ 25% breast density.
- Prior mammogram report indicating <25% breast density.
- Breast implants
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description B: Routine Mammogram + tomosynthesis Tomosynthesis Routine Mammogram and tomosynthesis A: routine 2D mammogram 2D Mammogram Subject receives regular 2D mammogram.
- Primary Outcome Measures
Name Time Method Interpretation Time of Scan Within 1 month of receiving scan
- Secondary Outcome Measures
Name Time Method Discomfort Scale Immediately after the subject receives scan Recall Rates 6 month intervals for 2 years after initial scan
Trial Locations
- Locations (1)
Alberta Screen Test
🇨🇦Edmonton, Alberta, Canada